Inside our bodies, our cells move around, communicate, form new tissue, and heal wounds with the help of proteins called integrins. But when disease occurs, integrins get the wrong cues and do damage—they might help tumors grow, or promote inflammation or scarring inside the body. Several drugs to block bad integrin behavior and treat a range of maladies have come to market. But they have a record of going awry, too, with sometimes lethal side effects.
Just another billion-dollar exit for a Massachusetts company most people have never heard of. This one has an interesting backstory, in a field rife with consolidation and would-be deals.
The first clinical trial for a Zika virus vaccine just received a green light from the FDA. Inovio Pharmaceuticals and GeneOne Life Science announced on Monday that their vaccine, called GLS-5700, will undergo phase I clinical testing for safety in 40 healthy volunteers within a few weeks.
A new survey has found that depression among Greeks has dramatically increased, with women being most severely affected.
Greece’s Statistical Authority survey on health is carried out every four years. The first one was conducted in 2009.
After six years of recession, Greece’s public healthcare system has been under enormous pressure due to austerity policies.
12.9% of Greece’s population stressed that it did not receive at all, or received delayed medical care due to a long waiting list, remoteness or problems in transportation (5%), and 9.4% due to lack of doctors and health specialties.
Private companies in the mobile industry have seen tremendous 661% growth in funding over the past 5 years.
What are the specific industry categories that have been most targeted by investments, and where are deals more thin on the ground?
Using CB Insights data, we drilled into deals to private mobile companies broken down by our subindustry classifications to highlight more saturated areas vs. growth opportunities within mobile. The resulting heat map shows deal activity by CB Insights’ subindustry classifications.
Healthcare, advertising, sales & marketing, and business intelligence startups using AI technologies received the highest number of deals in 2015 compared to other sub-industries; healthcare is dominating 2016 so far.
Nano Textile has developed a technology that can transform any fabric into one that kills bacteria, the Ramat Gan, Israel-based company said in a statement.
The company said the cost-effective technology permanently prevents the growth of bacteria on both natural and synthetic fibers, can prevent the spread of hospital-acquired infections and can reduce cross contamination between patients and medical staff, helping reduce secondary infections.
Two days after news from one anemia drug program sent its stock down more than 20 percent, Agios Pharmaceuticals (NASDAQ: AGIO) is reporting promising data from a second anemia treatment.
In an interview, CEO David Schenkein downplayed the information, which emerged Thursday, that a healthy volunteer developed thrombocytopenia, or low platelets, after taking the experimental AG-519 for 14 days.
In movies and television, streaming services like Netflix (NASDAQ: NFLX) are rendering DVDs obsolete. In music, Spotify and other Web applications are replacing MP3s, which themselves supplanted CDs not so long ago.
In healthcare, where the unauthorized transmission of patients’ protected health information (PHI) can result in steep fines or even jail time, some are welcoming the shift from physical to cloud-based storage.
Medical device company LDR Holdings (NASDAQ: LDRH) has been acquired for about $1 billion in cash by fellow device manufacturer Zimmer Biomet (NYSE: ZBH).
